<DOC>
	<DOCNO>NCT01151657</DOCNO>
	<brief_summary>The study aim investigate effect probiotic IBS-patients symptom compare placebo , give 6 month . By draw investigator give IBS patient , age 18-50 year , capsule either probiotic placebo . The patient take 2x2 capsule / day 6 month . The patient follow 1 year . They see 3 , 6 12 month , follow mean monthly letter . The capsule contain 3 different probiotic strain - Lactobacillus paracasei ssp paracasei F19 , Lactobacillus acidophilus La5 Bifidobacterium Bb12 . The dose 2 x 109 - 10 x 109 CFU/capsule . The hypothesis , clinical difference group receive probiotic group receive placebo .</brief_summary>
	<brief_title>Probiotics Irritable Bowel Syndrome</brief_title>
	<detailed_description>Background : In management IBS , treatment show great efficacy . IBS non-fatal disease , safety high priority choice treatment . Probiotics dietary supplement adverse effect . In study show beneficial effect IBS patient symptom , result questionable . The study long duration , patient probiotic capsule instead milk base drink .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Fulfill ROME III criterion age 1850 year sign informed content Danger signal ( fever , anaemia , weightloss , blod stool , predisposition CRC IBD ) abnormal physical examination comorbidity abuse lack ability talk understand danish pregnancy For patient &gt; 40 year . Changed bowel habit , duration &gt; 3 week , &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>IBS</keyword>
	<keyword>Irritable bowel syndrome</keyword>
	<keyword>Probiotics</keyword>
	<keyword>Treatment</keyword>
	<keyword>Adequate relief</keyword>
</DOC>